BioNTech, Fosun Pharma, Pfizer working on COVID-19 vaccine. Clinical testing in Germany in April

BioNTech SE said Monday its development a potential vaccine to induce immunity and prevent COVID-19 infection in response to the growing global health threat posed by the disease has seen rapid progress. BioNTech’s product candidate, BNT162, is a potential first-in-class mRNA vaccine in the worldwide effort against COVID-19.

Read more